<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02494752</url>
  </required_header>
  <id_info>
    <org_study_id>229/RC/KEMU</org_study_id>
    <nct_id>NCT02494752</nct_id>
  </id_info>
  <brief_title>Role of Mesenchymal Stem Cells in Fat Grafting</brief_title>
  <official_title>Potential of Mesenchymal Stem Cell Enriched Adipose Tissue Grafting for Contour Deformities of Face</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Edward Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Edward Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Contour deformity of face causes both functional as well as aesthetic problems for the
      patient. Fat being an autologous tissue source is considered as an ideal soft-tissue filler
      because it is abundant, readily available, inexpensive, host compatible, and can be harvested
      easily and repeatedly. However absorption of grafted fat is a major problem resulting in lack
      of consistency of final clinical outcome. Adipose tissue derived mesenchymal stem cells have
      the potential to enhance the viability of the grafted fat and the reliability of the final
      outcome of surgery. In the current study potential of mesenchymal stem cells will be studied
      by comparing two groups of patients requiring fat grafting for contour deformities of face.
      Control group will have fat graft with out enrichment with stem cells whereas experimental
      group will have their fat graft enriched with mesenchymal stem cells. Comparison will be made
      regarding viability of grafted fat in two groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Contour deformities of the face requiring soft tissue augmentation often result from
      conditions such as congenital disorders, acquired diseases, and traumatic and developmental
      deformities. Significant contour deformity of face causes both functional as well as
      aesthetic problems for the patient. Conventionally, these problems are treated by allogenic
      fillers, major flap surgery and fat grafting.1 However; different problems are associated
      with above mentioned treatment options. For example, allogenic fillers are foreign material
      that poses not only allergic reactions but also rapid absorption at the site of application.
      Similarly, flap surgery, in the form of pedicled and free flaps, produces considerable donor
      site morbidity. In addition, fine- tuning is impossible with flap, and tissue transferred in
      the form of flap may act as blob.

      Autologous fat grafting has gained pervasive acceptance for the management of contour
      deformities of the face. Fat being an autologous tissue source is considered as an ideal
      soft-tissue filler because it is abundant, readily available, inexpensive, host compatible,
      and can be harvested easily and repeatedly.2 Although the practice of fat grafting is not new
      and it is a safe and natural method of soft-tissue augmentation, the viability and
      reliability of transplanted fat grafts remains poorly studied. One major concern is the lack
      of consistency of final clinical outcome, which often requires multiple fat grafting
      procedures making it expensive. Rate of fat absorption may reach up to 40% to 80%.However,
      previously published data have failed to produce a cohesive algorithm of the required
      components for successful, consistent and durable fat transplantation.3 In order to overcome
      problems associated with fat grafting, other innovative techniques are required.

      The role of fat auto-transplantation in plastic surgery has evolved from a controversial
      technique designed for simple volume augmentation to the foundation for the innovative and
      burgeoning field of regenerative medicine. This is based on the fact that adipose tissue
      contains adipocytes and the stromal vascular fraction (SVF) consisting of multiple cell types
      such as circulating blood cells, fibroblasts, pericytes, endothelial cells, and mesenchymal
      stem cells (MSCs). Adipocytes account for 20 percent or fewer of the total number of cells in
      adipose tissue4whereasthere are only 3% MSCs in SVF of adipose tissue.5 Although this
      percentage is relatively low, this cell type is the main contributor in overall healing
      process. MSCs derived from adipose tissue (AT-MSCs) have high proliferative potential and
      ability to differentiate into mesenchymal (adipose, bone, cartilage) and non-mesenchymal
      (neuron like cells) lineages.6,7,8 AT-MSCs have been shown to enhance angiogenesis, decrease
      apoptosis and modify the local inflammatory response owing to their immunosuppressive and
      immunomodulatory properties.9 Therefore, the current study is designed to evaluate the effect
      of fat grafting and AT-MSCs together on contour deformities of face. By combining traditional
      fat graft with AT-MSCs, tissue viability and therefore the consistency of graft survival may
      be improved. In the current model investigators propose that transferred fat may act as a
      natural scaffold and temporary filler to restore the volume immediately while AT-MSCs will
      start participating in multiple parameters of tissue regeneration. This model supports the
      &quot;host replacement theory&quot; that has been put forward to describe how fat grafts survive after
      they are transplanted.10 Due to problems associated with fat grafting alone, it is desirable
      to solve such issues by using innovating techniques. In the current study investigators
      propose the novel idea of enrichment of conventional fat graft with ex-vivo expanded AT-MSCs
      to enhance the viability of the grafted fat and the reliability of the final outcome of
      surgery. Recent animal studies have suggested that AT-MSCs that have been expanded before
      administration could help preserve grafted fat and improve outcomes.11 Thus rationale of
      current study is to compare the outcome of conventional fat grafting with stem cell enriched
      fat grafting for contour deformities of face. If enrichment of fat graft with AT-MSCs can
      decrease its absorption rate, this innovative strategy can make fat transfer a reliable
      option for soft tissue augmentation. This can definitely improve final clinical outcome at
      lesser cost and reduced donor site morbidity
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in thickness of subcutaneous tissue</measure>
    <time_frame>24 weeks</time_frame>
    <description>Objective assessment will be made by doing baseline B mode colour Doppler ultrasonography of the treated area.The operator blinded to the group allocation will measure the thickness of the subcutaneous tissue (in millimeters) in the treated area during the baseline examination with ultrasound B-mode. In order to have a reproducible measurement in subsequent examinations, the operator will look for and note down precise anatomical landmarks or, in case of large areas, will mark the points with an indelible marker, saving a digital image for future reference. Patients will again under go ultrasonography of the treated area at 24 weeks post treatment. During this repeat ultra sonography same operator will again measure the subcutaneous thickness of the treated in millimeters. The difference in two measurements will be noted down as residual volume. Means of residual volumes in two groups will be compared.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from base line in post operative appearance</measure>
    <time_frame>24 weeks</time_frame>
    <description>Subjective assessment will be done by taking photographs preoperatively and 24 weeks post treatment months under standard conditions of light, distance, views and camera make. Two plastic surgeons blinded to group allocation will rate post operative appearance as satisfactory/unsatisfactory by comparing pre and post operative photographs.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Romberg's Disease</condition>
  <condition>Craniofacial Microsomia</condition>
  <condition>Lipodystrophy</condition>
  <condition>Mixed Connective Tissue Disease</condition>
  <arm_group>
    <arm_group_label>Stem cell enriched</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fat graft will be enriched with ex vivo expanded stem cells</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non stem cell enriched</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fat graft will not be enriched with ex vivo expanded stem cells</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fat graft enriched with ex vivo expanded stem cells</intervention_name>
    <description>Fat graft will be enriched with ex vivo expanded stem cells</description>
    <arm_group_label>Stem cell enriched</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fat graft not enriched with ex vivo expanded stem cells</intervention_name>
    <description>Fat graft will not be enriched with ex vivo expanded stem cells</description>
    <arm_group_label>Non stem cell enriched</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with congenital and acquired contour deformities of face requiring soft
             tissue augmentation .

          -  Must be 16-60 years of age

          -  Must be American Society of Anesthesiology (ASA) class 1 and 2

        Exclusion Criteria:

          -  Patients with contour deformities in which skin is adherent to facial skeleton

          -  Contour deformities underlying skin grafted areas of face

          -  Abdominal skin pinch thickness less than 3 inch
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Muhammad M Bashir, F.C.P.S</last_name>
    <phone>923336517745</phone>
    <email>mmbashir1@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mahmood S Chaudhry, PhD</last_name>
    <phone>923214110894</phone>
    <email>ms20031@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Cheong YW, Lo LJ. Facial asymmetry: etiology, evaluation, and management. Chang Gung Med J. 2011 Jul-Aug;34(4):341-51. Review.</citation>
    <PMID>21880188</PMID>
  </reference>
  <reference>
    <citation>Bucky LP, Kanchwala SK. The role of autologous fat and alternative fillers in the aging face. Plast Reconstr Surg. 2007 Nov;120(6 Suppl):89S-97S.</citation>
    <PMID>18090347</PMID>
  </reference>
  <reference>
    <citation>Gir P, Brown SA, Oni G, Kashefi N, Mojallal A, Rohrich RJ. Fat grafting: evidence-based review on autologous fat harvesting, processing, reinjection, and storage. Plast Reconstr Surg. 2012 Jul;130(1):249-58. doi: 10.1097/PRS.0b013e318254b4d3. Review.</citation>
    <PMID>22743888</PMID>
  </reference>
  <reference>
    <citation>Brown SA, Levi B, Lequeux C, Wong VW, Mojallal A, Longaker MT. Basic science review on adipose tissue for clinicians. Plast Reconstr Surg. 2010 Dec;126(6):1936-46. doi: 10.1097/PRS.0b013e3181f44790. Review. Erratum in: Plast Reconstr Surg. 2011 Feb;127(2):1025. Lequex, Charlotte [corrected to Lequeux, Charlotte].</citation>
    <PMID>21124133</PMID>
  </reference>
  <reference>
    <citation>Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012;2012:812693. doi: 10.1155/2012/812693. Epub 2012 Apr 12.</citation>
    <PMID>22577397</PMID>
  </reference>
  <reference>
    <citation>Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT. Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. J Transl Med. 2014 Jan 7;12:8. doi: 10.1186/1479-5876-12-8.</citation>
    <PMID>24397850</PMID>
  </reference>
  <reference>
    <citation>Choudhery MS, Badowski M, Muise A, Harris DT. Comparison of human mesenchymal stem cells derived from adipose and cord tissue. Cytotherapy. 2013 Mar;15(3):330-43. doi: 10.1016/j.jcyt.2012.11.010. Epub 2013 Jan 11.</citation>
    <PMID>23318344</PMID>
  </reference>
  <reference>
    <citation>Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT. Cryopreservation of whole adipose tissue for future use in regenerative medicine. J Surg Res. 2014 Mar;187(1):24-35. doi: 10.1016/j.jss.2013.09.027. Epub 2013 Oct 8.</citation>
    <PMID>24268882</PMID>
  </reference>
  <reference>
    <citation>Tiryaki T, Findikli N, Tiryaki D. Staged stem cell-enriched tissue (SET) injections for soft tissue augmentation in hostile recipient areas: a preliminary report. Aesthetic Plast Surg. 2011 Dec;35(6):965-71. doi: 10.1007/s00266-011-9716-x. Epub 2011 Apr 13.</citation>
    <PMID>21487913</PMID>
  </reference>
  <reference>
    <citation>Eto H, Kato H, Suga H, Aoi N, Doi K, Kuno S, Yoshimura K. The fate of adipocytes after nonvascularized fat grafting: evidence of early death and replacement of adipocytes. Plast Reconstr Surg. 2012 May;129(5):1081-92. doi: 10.1097/PRS.0b013e31824a2b19.</citation>
    <PMID>22261562</PMID>
  </reference>
  <reference>
    <citation>Gir P, Oni G, Brown SA, Mojallal A, Rohrich RJ. Human adipose stem cells: current clinical applications. Plast Reconstr Surg. 2012 Jun;129(6):1277-90. doi: 10.1097/PRS.0b013e31824ecae6. Review.</citation>
    <PMID>22634645</PMID>
  </reference>
  <reference>
    <citation>KÃ¸lle SF, Fischer-Nielsen A, Mathiasen AB, Elberg JJ, Oliveri RS, Glovinski PV, Kastrup J, Kirchhoff M, Rasmussen BS, Talman ML, Thomsen C, Dickmeiss E, Drzewiecki KT. Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet. 2013 Sep 28;382(9898):1113-20. doi: 10.1016/S0140-6736(13)61410-5.</citation>
    <PMID>24075051</PMID>
  </reference>
  <reference>
    <citation>Bollero D, Pozza S, Gangemi EN, De Marchi A, Ganem J, A M el K, Faletti C, Stella M. Contrast-enhanced ultrasonography evaluation after autologous fat grafting in scar revision. G Chir. 2014 Nov-Dec;35(11-12):266-73.</citation>
    <PMID>25644727</PMID>
  </reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2015</study_first_submitted>
  <study_first_submitted_qc>July 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2015</study_first_posted>
  <last_update_submitted>July 9, 2015</last_update_submitted>
  <last_update_submitted_qc>July 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King Edward Medical University</investigator_affiliation>
    <investigator_full_name>Muhammad Mustehsan Bashir</investigator_full_name>
    <investigator_title>Associate professor of Plastic Surgery</investigator_title>
  </responsible_party>
  <keyword>Contour deformities of face</keyword>
  <keyword>autologous fat grafting</keyword>
  <keyword>Post traumatic facial contour defects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipodystrophy</mesh_term>
    <mesh_term>Connective Tissue Diseases</mesh_term>
    <mesh_term>Mixed Connective Tissue Disease</mesh_term>
    <mesh_term>Goldenhar Syndrome</mesh_term>
    <mesh_term>Facial Hemiatrophy</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 31, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

